--- title: "Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio?" description: "Last week (Feb. 2–Feb. 6), several large-cap stocks experienced significant declines due to weak earnings and analyst downgrades. Stellantis led the losses with a 26.24% drop after warning of a full-y" type: "news" locale: "en" url: "https://longbridge.com/en/news/275230299.md" published_at: "2026-02-08T13:39:17.000Z" --- # Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? > Last week (Feb. 2–Feb. 6), several large-cap stocks experienced significant declines due to weak earnings and analyst downgrades. Stellantis led the losses with a 26.24% drop after warning of a full-year net loss. Gartner fell 25.41% following disappointing fourth-quarter results and lowered guidance. PayPal decreased by 22.92% after reporting worse-than-expected results. Other notable losers included Reddit, IREN, Thomson Reuters, Atlassian, Novo Nordisk, IQVIA, and Boston Scientific, all facing similar analyst downgrades and poor financial performance. These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? **Stellantis N.V.** (NYSE:STLA) slumped 26.24% this week after the company warned of a full-year net loss. **Gartner, Inc.** (NYSE:IT) fell 25.41% this week after the company issued fourth-quarter financial results and issued FY26 guidance. Also, multiple analysts lowered their price forecast on the stock. **PayPal Holdings, Inc.** (NASDAQ:PYPL) decreased 22.92% this week after the company reported worse-than-expected fourth-quarter financial results and named Enrique Lore As CEO. Also, multiple analysts lowered their price forecast on the stock. **Reddit, Inc.** (NYSE:RDDT) slumped 23.10% this week. Multiple analysts lowered their price forecasts on the stock. **IREN Limited** (NASDAQ:IREN) fell 20.14% this week after the company reported worse-than-expected second-quarter financial results. **Thomson Reuters Corp** (NASDAQ:TRI) decreased 20.51% this week after multiple analysts lowered their price targets following the company’s fourth-quarter results. **Atlassian Corporation** (NASDAQ:TEAM) fell 19.64% this week after the company reported its second-quarter financial results. Also, multiple firms lowered their respective price targets on the stock. **Novo Nordisk** (NYSE:NVO) decreased 17.75% this week after the company reported fourth-quarter financial results. The company expects FY26 adjusted sales guidance to decline.  **Hims & Hers Health Inc**. (NYSE:HIMS) announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as **Novo Nordisk's Wegovy.** **IQVIA Holdings, Inc.** (NYSE:IQV) fell 18.63% this week. The company reported fourth-quarter financial results and issued FY26 EPS guidance below estimates. **Boston Scientific Corporation** (NYSE:BSX) slumped 18.61% this week after the company reported quarterly results. Also, multiple analysts lowered their price forecasts on the stock. ### Related Stocks - [PYPL.US - Paypal](https://longbridge.com/en/quote/PYPL.US.md) - [BSX.US - Boston Scientific](https://longbridge.com/en/quote/BSX.US.md) - [STLA.US - Stellantis NV](https://longbridge.com/en/quote/STLA.US.md) - [IT.US - Gartner](https://longbridge.com/en/quote/IT.US.md) - [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/en/news/275652909.md) | | Stellantis revives several diesel models in Europa | Stellantis is reviving diesel versions of at least seven car and van models in Europe, reversing its previous phase-out | [Link](https://longbridge.com/en/news/276047229.md) | | Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total | [Link](https://longbridge.com/en/news/275761183.md) | | Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/en/news/275789396.md) | | Novo’s Wegovy spot tops pharma Super Bowl engagement rankings | Novo Nordisk's Wegovy ad topped the pharma engagement rankings during Super Bowl LX, focusing on building trust rather t | [Link](https://longbridge.com/en/news/275368919.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.